Endo to buy Par Pharma for about $8 billion By: MarketWatch May 18, 2015 at 07:59 AM EDT Endo International agrees to buy Par Pharmaceutical Holdings from private-equity firm TPG for about $8 billion in cash and stock. Read More >> Related Stocks: Endo Int'l Plc Macy's